BAWAT WATER TECHNOLOGIES’ OFFERING IS COMPLETE

Posted on 7. April 2022

The IPO will be carried out as a new issue of Units securing Bawat Water Technologies AB a transaction proceed of up to SEK 56.7 million. Translution Capital acted as exclusive financial advisor to Bawat Water Technologies AB and is pleased to congratulate CEO Marcus P. Hummer and the full Bawat Water Technologies AB team with this successful transaction. The IPO proceeds will allow the Company to make the most of the momentum they already are experiencing and further strengthen their international sales and marketing presence – a journey we are excited to follow.

Expres2ion Biotechnologies exercise warrants

Posted on 23. September 2021

Translution Capital advises ExpreS2ion Biotechnologies (publ.) in a SEK 44m new issue based on the T05 warrant programme. We are pleased to congratulate the ExpreS2ion Biotechnologies team with the successful subscription level outcome of 97.4%. Proceeds will support the company to finance its vaccine and immunotherapy pipeline – a journey we are excited to follow.

Translution Capital advises CRisk Software ApS

Posted on 15. September 2021

Translution Capital advises the selling shareholders of CRISK Software ApS securing the full Trade Sale to Brady, backed by private equity firm, Hanover Investors Management. The transaction will further strengthen the Brady Technologies offering within enterprise risk management for the energy and commodities markets. Kindly join us congratulating Ali Celik and Lars Ribjerg, the founders of Crisk Software, on this successful transaction. It was a pleasure working with you.